Using the IPS algorithm, we evaluated the immune landscape of SCLC tumors, including MHC molecules, effector immune cells (ECs), suppressive immune cells (SCs), and immune checkpoints (ICs), in two SCLC datasets (sclc_ucologne_2015 and GSE60052). The gene discussed is HLA-C; the disease is small cell lung carcinoma.